Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "U.S. Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, Devices), By Sales Channel (Prescriptions, OTC), By Gender, By End Use, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.
The U.S. androgenetic alopecia market was valued at USD 979.1 million in 2024 and is expected to grow at a CAGR of 6.6% from 2025 to 2030
The increasing incidence of Androgenic Alopecia (AGA) is driving market growth. Androgenetic alopecia, the most common form of hair loss, affects a significant portion of the population, with aging and genetic factors playing a role. As awareness about hair loss solutions rises, more individuals seek treatments, expanding the market. According to data published by the National Library of Medicine in July 2023, approximately 50 million men and 30 million women in the U.S. were affected by androgenetic alopecia (AGA). 
Another factor is the advancement in treatment options. The market has witnessed the introduction of innovative therapies, such as topical solutions, oral medications, and minimally invasive procedures such as platelet-rich plasma (PRP) therapy and hair transplant surgeries. Pharmaceutical companies also invest in research and development to create more effective and convenient treatments, attracting a broader consumer base.
The approval of new drugs and the expansion of over-the-counter products further propel market growth. In June 2025, Pelage Pharmaceuticals announced positive Phase 2a trial results for PP405, a topical treatment targeting hair loss by reactivating dormant hair follicle stem cells. This advancement positions Pelage as a leader in regenerative medicine for androgenetic alopecia.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $979.1 Million |
| Forecasted Market Value (USD) by 2030 | $1420 Million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | United States |
Competitive Landscape
- Johnson & Johnson Services, Inc.
- Cipla
- Sun Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma Limited
- Hairmax International, LLC
- Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
- Curallux, LLC
- Apira Science, Inc. (iGROW Laser)
- Theradome Inc.
- Recent Developments & Impact Analysis, By Key Market Participants
- Company/Competition Categorization
- Vendor Landscape
- Key company heat map analysis, 2024
- Company overview
- Financial performance
- Product benchmarking
- Strategic initiatives
U.S. Androgenetic Alopecia Market Report Segmentation
Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceuticals
- Devices
End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Homecare Settings
- Dermatology Clinics
Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Prescriptions
- OTC
Gender Outlook (Revenue, USD Million, 2018 - 2030)
- Male
- Female
For more information about this report visit https://www.researchandmarkets.com/r/gmzf5s
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
